ALEXANDRE MOREAU

ALEXANDRE MOREAU is the Country President for China at UCB, a global biopharmaceutical company. He has over 25 years of experience in the pharmaceutical and biotech industries, with a strong focus on leadership and business development. Moreau has a proven track record in managing cross-functional teams, driving innovation, and executing complex strategic projects.

Professional Background

• Current Position: Country President, China at UCB (April 2022 - Present)
• Previous Roles:
  • Vice President - Global Leadership Team at UCB (July 2018 - July 2023)
  • Chief Executive Officer at Kymo Therapeutics Limited (March 2017 - June 2018)
  • Chief Executive Officer at Mavalon Therapeutics Limited (March 2017 - June 2018)
  • Global Product Strategy - Vice President at Roche Genentech (2010 - February 2017)
  • Global Marketing - Vice President at Sanofi (2007 - 2010)
  • Marketing & Sales Leadership at Novartis (2000 - 2007)

Education

• Harvard Business School: General Management Program Graduate
• INSEAD: Advanced Management Program Graduate
• Sorbonne Graduate Business School: Master in Business Administration
• University of Biological & Pharmaceutical Sciences: Doctor in Pharmacy

Skills and Attributes

Moreau is recognized for his ability to motivate teams and his commitment to ethical practices in healthcare. He is multilingual, speaking English, French, and German, and has a strong educational background that includes both scientific and business training from prestigious institutions.1